Beruflich Dokumente
Kultur Dokumente
The current recommendation for a first colonoscopy is at age 50 for both men
and women. Yet, evidence suggests that this recommendation be revised to
reflect differences in the development of colon tumors based on sex. It appears
that tumors appear at younger ages in men, according to an Austrian study
looking at Sex-Specific Prevalence of Colorectal Cancer in Individuals Undergoing
Screening Colonoscopy. M Ferlitsch et al. JAMA. 2011;306(12):1352-1358.
Among men ages 50 to 54, the prevalence of adenomas was 18.5% compared
with 10.7% for women at the same age. More telling is the prevalence of these
adenomas in men in their early 50s which were similar to the 17.9% (95% CI
16.7 to 19.1) seen in women ages 65 to 69,
The findings suggest that "male sex constitutes an independent risk factor for
colorectal carcinoma and indicating new sex-specific age recommendations for
screening colonoscopy," according to the study authors. However, not all experts
agree.
Since the ideal age for screening has not been fully explored, these researchers
examined data from a national colonoscopy screening program in which the
median ages for women and men were 60.7 and 60.6, respectively.
Only when women were ten years older did their prevalence of advanced
adenomas equal that of men in their early 50s. For colorectal cancer, men had a
twofold increase in risk with there a ten-year differential in prevalence.
The authors acknowledge that potential confounding factors such as obesity and
family history were not accounted for. Despite these findings, changing the ages
for colonoscopy screening -- particularly for women -- could create problems,
according to Sidney J. Winawer, MD, of Memorial Sloan-Kettering Cancer Center
in New York City. The old message was that colon cancer was a man's disease. “
Of 2616 women eligible for CRCS, 2005 (77%) declined to participate, and 611
(23%) were enrolled. Even among those who refused participation, there was a
high interest in CRCS. Lack of medical insurance was the leading barrier to
CRCS, but alternative funding partially overcame this obstacle. Of the 611
women enrolled in the study, 337 (55%) underwent screening colonoscopy, and
49 (15%) had adenomatous polyps.
"Considering that the cost effectiveness of breast and colon cancer screening is
comparable, formulating a funding strategy for CRCS for the uninsured similar to
that used for breast cancer screening could improve CRCS in minority
populations," the study authors write. "...Attempts to enhance colorectal cancer
screening in this population by media campaigns, provision of fecal occult-blood
test (FOBT) cards and other methods have usually not met with much success. It
appears that a comprehensive program is needed in medically underserved
areas."
The National Cancer Institute and the American Cancer Society supported this
study. The study authors have disclosed no relevant financial relationships.